He also serves as Associate Director for Clinical Sciences at City of Hope National Medical Center.
[2] During his fellowship in Professor James Griffin's laboratory at Harvard, Salgia worked on the cytoskeleton, signal transduction pathways and hematpoiesis/Chronic myelogenous leukemia.
[3][4][5][6] He was the first to fully clone the focal adhesion protein paxillin (human and chicken) and demonstrate its role in oncogenic transformation.
[7] As an independent clinician-scientist, Salgia's major research interests include elucidating how the receptor tyrosine kinases affect cell growth, and understanding tumor heterogeneity, including the role of cell-signaling pathways, mitochondria, immunology, and mathematical modeling[8] Salgia was born in Indore, Madhya Pradesh, India.
He continued his postgraduate training with an internship and residency in internal medicine at the Johns Hopkins Hospital in Baltimore, followed by a fellowship in medical oncology at Dana–Farber Cancer Institute in Boston, during which time he also served as a clinical fellow at Harvard Medical School in Boston.